Anatomy of a Breakthrough
Jedd Wolchok, MD, PhD, a melanoma specialist who led the clinical trials of the first immunotherapy drug approved by the FDA. Watch Dr. Wolchok’s patient Karen describe how this groundbreaking treatment saved her life.
Our Mission
To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. Since its founding in 1946, Damon Runyon has invested nearly $355 million and funded nearly 3,700 young scientists.
Race to the Top of Salesforce Tower Benefits Cancer Research
Approximately 450 supporters took part in Runyon Up, the first fundraising stair climb held at the newly opened Salesforce Tower in San Francisco on October 21. Climbers faced a unique vertical challenge in the 61-story building, the tallest in San Francisco, and were rewarded with breathtaking views.
YUNG S. LIE, PHD, NAMED DAMON RUNYON'S NEXT LEADER
Yung S. Lie, PhD, was appointed the incoming President and Chief Executive Officer of the Damon Runyon Cancer Research Foundation. Dr. Lie succeeds Lorraine W. Egan, who will step down in December. Read about Dr. Lie, a former Damon Runyon fellow, as she leads our efforts to end cancer.
